Vascular Therapeutics' Other Investors

Vascular Therapeutics raised a round of funding on , . Investors include Domain Associates.

Biopharmaceuticals for the prevention and treatment of vascular disease. Acquired by GlycoDesign, since acquired by Inflazyme…

Articles about Vascular Therapeutics' Other Investors: